Ligand validation:3V9L

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3V9L designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V9L_NAD_B_1517	89%	22%	0.074	0.954	1.94	1.33	9	7	0	0	100%	0.5227
3V9L_NAD_A_1518	87%	21%	0.081	0.952	1.93	1.37	10	10	0	0	100%	0.5227
7MES_NAD_B_601	59%	23%	0.083	0.951	1.34	1.82	3	7	0	0	52%	0.5227
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.